High-Frequency Monitoring for Early Detection of Cisplatin Ototoxicity
Authors:
- James A. HenryJHJames A. Henry
- Heidi I. SchafferHSHeidi I. Schaffer
- Deanna J. OlsonDODeanna J. Olson
- Richard H. FreyRFRichard H. Frey
- Grover C. BagbyGBGrover C. Bagby
- 1 June 1993
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 119 (6) , 661-666
Abstract
• Cisplatin can cause irreversible hearing loss initially detectable as impairment of high-frequency hearing with progression to lower frequencies. Many patients receiving cisplatin are too ill to tolerate lengthy audiometric testing. Therefore, a rapid and sensitive high-frequency monitoring strategy to detect cisplatin-induced ototoxicity is needed. Serial conventional (0.25 to 8 kHz) and high-frequency (≥8 kHz) threshold monitoring was performed in patients receiving cisplatin, resulting in 84% of ears showing hearing loss, of which 71% were detected first in frequencies of 8 kHz or greater. By analysis according to an individualized, specific high-frequency range, early identification of hearing loss occurred in 94% of ears showing change. This five-frequency procedure is a sensitive detector of ototoxicity and is proposed as an alternative monitoring protocol for patients receiving cisplatin who cannot tolerate extended testing. (Arch Otolaryngol Head Neck Surg. 1993;119:661-666)Keywords
This publication has 15 references indexed in Scilit:
- Ototoxicity of cisplatinum in children and adolescentsBritish Journal of Cancer, 1990
- Acute Onset Deafness in a 4-Year-Old Girl After a Single Infusion of Cis-PlatinumPediatric Hematology and Oncology, 1990
- A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian CancerActa Oncologica, 1989
- Ototoxicity of high‐dose cisplatin by bolus administration in patients with advanced cancers and normal hearingThe Laryngoscope, 1988
- Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus.Journal of Clinical Oncology, 1987
- High-dose cisplatin in advanced head and neck cancerCancer Chemotherapy and Pharmacology, 1987
- Clinical Features of Cisplatin Vestibulotoxicity and Hearing LossORL, 1987
- Early detection of cisplatin ototoxicity selected case reportsCancer, 1984
- Neurotoxic Effects of Cisplatin TherapyArchives of Neurology, 1982
- Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patientsJournal of Surgical Oncology, 1981